Clinical Trials

CLINICAL TRIAL: Hidradenitis Suppurativia, Vitiligo, and Atopic Dermatitis

Dermatology Specialists of Charlotte are enrolling patients in trials for the treatment of Hidradenitis Suppurativia, Vitiligo, and Atopic Dermatitis. All patients will continue to be managed by the referring provider/establish providers outside of visits to our clinic for study related activities. If a subject qualifies for the trial, all medical care related to the trial and the study medication will be supplied at no cost. The subject will also be paid a stipend for their time and travel expenses. 

The main study requirements are listed below for Hidradenitis Suppurativia:

• 18 -75 years of age with a diagnosis of at least 12 months
• HS lesions in at least 2 distinct anatomical regions
• Did not respond to, or could not tolerate, a 28-day course of oral antibiotics at any time
• Have a total abscess and inflammatory nodule count greater than or equal to 5

The main study requirements are listed below for Vitiligo:

• 18 years of age and older
• Diagnosis of nonsegmental vitiligo of at least 3 months
• BSA of 4%-60% with > 0.5% on the face
•  F-VASI > 0.5 and T-VASI > 3

The main study requirements are listed below for Atopic Dermatitis:

• 12 years of age or older with a diagnosis of at least 1 year
• BSA > 10%, vIGA > 3, EASI > 16
• Inadequate response to topical steroids
• Tried Dupilumab (lack of efficacy, intolerance, or cost)

If you have any patients that may be interested or have questions regarding the trial, please reach out to Abbey Harwell at 704-247-9179 ext. 212 or abbey.harwell@djlresearch.com.